CRISPR
$78.38
$78.38
+$1.15 (+1.48%) Today
-$0.23 (-0.29%) As of 12:00 AM UTC after-hours
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CEOSamarth Kulkarni
CEOSamarth Kulkarni
Employees473
Employees473
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2013
Founded2013
Employees473
Employees473
CRSP Key Statistics
Market cap6.09B
Market cap6.09B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.31M
Average volume1.31M
High today$80.10
High today$80.10
Low today$76.39
Low today$76.39
Open price$77.54
Open price$77.54
Volume902.75K
Volume902.75K
52 Week high$135.70
52 Week high$135.70
52 Week low$42.51
52 Week low$42.51
CRSP News
Benzinga 5d
Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US - Yahoo FinanceBarclays says that CRISPR Therapeutics AG's (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical prog...
Analyst ratings
63%
of 27 ratingsBuy
63%
Hold
33.3%
Sell
3.7%
CRSP Earnings
-$2.40
$1.55
$5.49
$9.44
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated-$2.23 per share
Estimated-$2.23 per share
Actual-$2.40 per share
Actual-$2.40 per share